Gereon Rieke

2.6k total citations
9 papers, 265 citations indexed

About

Gereon Rieke is a scholar working on Infectious Diseases, Oncology and Neurology. According to data from OpenAlex, Gereon Rieke has authored 9 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Oncology and 2 papers in Neurology. Recurrent topics in Gereon Rieke's work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Immunotherapy and Immune Responses (2 papers). Gereon Rieke is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Immunotherapy and Immune Responses (2 papers). Gereon Rieke collaborates with scholars based in Germany, United States and Netherlands. Gereon Rieke's co-authors include Heidi A. Schreiber, Matthew M. Meredith, Jakob Loschko, Kai-Hui Yao, Michel C. Nussenzweig, Jacob Nattermann, Christoph Boesecke, Pierre Guermonprez, Virginia A. Pedicord and Daniel Mucida and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Infectious Diseases and Life Sciences.

In The Last Decade

Gereon Rieke

9 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gereon Rieke Germany	6	133	103	50	40	38	9	265
Barbara Baronio Italy	3	81 0.6×	187 1.8×	28 0.6×	61 1.5×	31 0.8×	4	258
Asma Boumaza France	8	87 0.7×	162 1.6×	9 0.2×	67 1.7×	37 1.0×	10	288
Jennifer Rebeles United States	5	60 0.5×	101 1.0×	21 0.4×	24 0.6×	38 1.0×	12	296
Junbin Wang China	7	48 0.4×	45 0.4×	15 0.3×	13 0.3×	41 1.1×	16	162
Patricia Almendro-Vázquez Spain	8	70 0.5×	130 1.3×	8 0.2×	58 1.4×	19 0.5×	12	191
Ane Fernandez Salinas Italy	7	131 1.0×	139 1.3×	8 0.2×	14 0.3×	22 0.6×	8	238
Patrick Mucher Austria	10	34 0.3×	261 2.5×	10 0.2×	36 0.9×	41 1.1×	14	357
Marion Humbert Switzerland	6	82 0.6×	93 0.9×	6 0.1×	49 1.2×	41 1.1×	7	212
Moritz Anft Germany	9	81 0.6×	98 1.0×	4 0.1×	67 1.7×	44 1.2×	25	238
Dídac Casas‐Alba Spain	8	25 0.2×	59 0.6×	54 1.1×	24 0.6×	126 3.3×	20	248

Countries citing papers authored by Gereon Rieke

Since Specialization

Citations

This map shows the geographic impact of Gereon Rieke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gereon Rieke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gereon Rieke more than expected).

Fields of papers citing papers by Gereon Rieke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gereon Rieke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gereon Rieke. The network helps show where Gereon Rieke may publish in the future.

Co-authorship network of co-authors of Gereon Rieke

This figure shows the co-authorship network connecting the top 25 collaborators of Gereon Rieke. A scholar is included among the top collaborators of Gereon Rieke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gereon Rieke. Gereon Rieke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Monin, Malte B., Moritz Berger, Robert Mahn, et al.. (2023). Impaired immunogenicity after vaccination for SARS-CoV-2 in patients with gastrointestinal cancer: does tumor entity matter?. Journal of Gastrointestinal Oncology. 14(3). 1218–1234. 2 indexed citations

Rieke, Gereon, Kathrin van Bremen, Jenny Bischoff, et al.. (2022). Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination. The Journal of Infectious Diseases. 225(10). 1688–1693. 12 indexed citations

Rieke, Gereon, et al.. (2022). Confirmed SARS-CoV-2 Reinfection After 1 Year in a Patient with X-linked Agammaglobulinaemia. 1(1). 35–35. 1 indexed citations

Bremen, Kathrin van, Malte B. Monin, Stefan Schlabe, et al.. (2022). Impact of COVID‐19 on HIV late diagnosis in a specialized German centre. HIV Medicine. 23(11). 1209–1213. 10 indexed citations

Bremen, Kathrin van, Malte B. Monin, Anna Maria Eis‐Hübinger, et al.. (2021). SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study). Infection. 49(5). 1039–1043. 1 indexed citations

Duerr, Georg Daniel, Annkristin Heine, Sebastian Zimmer, et al.. (2020). Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sciences. 260. 118400–118400. 26 indexed citations

Luetkens, Julian A., Alexander Isaak, Sebastian Zimmer, et al.. (2020). Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging. Circulation Cardiovascular Imaging. 13(5). e010897–e010897. 66 indexed citations

Loschko, Jakob, Gereon Rieke, Heidi A. Schreiber, et al.. (2016). Inducible targeting of cDCs and their subsets in vivo. Journal of Immunological Methods. 434. 32–38. 54 indexed citations

Loschko, Jakob, Heidi A. Schreiber, Gereon Rieke, et al.. (2016). Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation. The Journal of Experimental Medicine. 213(4). 517–534. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact